klow-80 peptide KLOW 80mg KLOW Peptide 80mg | Third-Party

Erythrocyte deformability and eryptosis during inflammation, and impaired blood rheology

From blurred or weakened vision to optic neuropathy and macular degeneration, these conditions can greatly affect your central vision

Overcoming the Blood-Brain Barrier A number of strategies have been investigated to overcome the limitations of the BBB in the treatment of brain cancers: the first is to bypass the BBB, the second is to increase its permeability, and the third is to use carrier molecules that are permeable to the BBB (2022)

Initial studies have confirmed its safety and efficacy in a small cohort of patients with immune-mediated DED (Watane et al., 2022)